Breaking News
December 15, 2018 - Gut bacteria may modify effectiveness of anti-diabetes drugs
December 15, 2018 - How imaginary friends could boost children’s development
December 15, 2018 - Study provides new insights into molecular mechanisms underlying role of amyloid in Alzheimer’s disease
December 15, 2018 - For the asking, a check is in the mail to help pay for costly drugs
December 15, 2018 - UA scientists uncover biological processes leading to rare brain disorder in babies
December 15, 2018 - The largest database on industrial poisons
December 15, 2018 - ESMO Immuno-Oncology Congress showcases novel technologies set to benefit many cancer patients
December 15, 2018 - Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
December 15, 2018 - Left ventricular noncompaction – Genetics Home Reference
December 15, 2018 - Children’s sleep not significantly affected by screen time, new study finds
December 15, 2018 - When should dementia patients stop driving? A new guidance for clinicians
December 15, 2018 - Researchers use INTEGRA’s VIAFLO 96/384 to streamline the experimental workflow
December 15, 2018 - Researchers discover protein involved in nematode stress response
December 15, 2018 - Cancer patients have greater risk of developing shingles, study shows
December 14, 2018 - UAlberta scientists identify biomarkers for detecting Alzheimer’s disease in saliva samples
December 14, 2018 - Study uncovers link between tube travel and spread of flu-like illnesses
December 14, 2018 - Caffeine plus another compound in coffee may fight Parkinson’s disease
December 14, 2018 - GW researchers review studies on treatments for prurigo nodularis
December 14, 2018 - Lack of peds preventive care ups unplanned hospital admissions
December 14, 2018 - Miscarriage: When Language Deepens Pain
December 14, 2018 - New method helps better understand pathological development of ALS
December 14, 2018 - Intellectually active lifestyle confers protection against neurodegeneration in Huntington’s patients
December 14, 2018 - Mammalian collagen nanofibrils become stronger and tougher with exercise
December 14, 2018 - Considerable Morbidity, Mortality Due to Animal Encounters
December 14, 2018 - Researchers find inhibiting one protein destroys toxic clumps seen in Parkinson’s disease
December 14, 2018 - How early physical therapy can lessen the long-term need for opioids
December 14, 2018 - Depression, suicide rates highest in Mountain West states
December 14, 2018 - New model could cure the potential to underestimate how quickly diseases spread
December 14, 2018 - Exercise-induced hormone activates cells critical for bone remodeling in mice
December 14, 2018 - Researchers discover new mechanism behind spread of malignant pleural mesothelioma
December 14, 2018 - Health Tip: Celebrate a Healthier Holiday
December 14, 2018 - Scalpel-free surgery enhances quality of life for Parkinson’s patients, study finds
December 14, 2018 - Early physical therapy can reduce risk, amount of long-term opioid use | News Center
December 14, 2018 - Genetic marker, predictor of early relapse in common childhood cancer discovered
December 14, 2018 - Study could lead to a potential new way of treating sepsis
December 14, 2018 - New protein complex helps embryonic stem cells to maintain their indefinite potential
December 14, 2018 - Salk professor receives $1.8 million from NOMIS Foundation for research on mechanisms to promote health
December 14, 2018 - New discovery will improve the safety and predictability of CRISPR
December 14, 2018 - Geneticists discover how sex-linked disorders arise
December 14, 2018 - New method to visualize small-molecule interactions inside cells
December 14, 2018 - Study describes mechanism that makes people more vulnerable to hunger-causing stimuli
December 14, 2018 - Chronic opioid therapy associated with increased healthcare spending and hospital stays
December 14, 2018 - Blood Types
December 14, 2018 - Obesity linked to increased risk of early-onset colorectal cancer
December 14, 2018 - Blood test helps identify distinct molecular signatures in children with cystic fibrosis
December 14, 2018 - In California, doctors accused of sexual misconduct often get second chances
December 14, 2018 - Scientists use water to track electrical activity of nerve cells
December 14, 2018 - Recurrence of urinary tract infection may depend on bacterial strain, study shows
December 14, 2018 - GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
December 14, 2018 - Partial Thromboplastin Time (PTT) Test: MedlinePlus Lab Test Information
December 14, 2018 - Common tactics for health promotion at work may be detrimental to employees with obesity
December 14, 2018 - Myths about migration and health not supported by available evidence
December 14, 2018 - Recent findings on rare genetic disorder may help develop new treatment options
December 14, 2018 - New drug shows promise in treating sarcomas
December 14, 2018 - Scientists perform lung lavage as new approach for tuberculosis diagnosis in rhinoceros
December 14, 2018 - Answering the Biggest Neurological Research Questions of Today
December 14, 2018 - Recent winners of the Nobel Medicine Prize
December 14, 2018 - KHN’s ‘What the Health?’ Insurance enrollment is lagging — and there are lots of reasons why
December 14, 2018 - Study assesses safety and efficacy of new treatment for pancreatic cancer
December 14, 2018 - Weakened metabolism of immune T cells may account for serious complications in elderly
December 14, 2018 - Study finds drug targets for Ebola, Dengue, and Zika viruses
December 14, 2018 - Face masks may offer protection against staph bacteria for hog farm workers and their household members
December 14, 2018 - Shining new light on neuron firing
December 14, 2018 - Study highlights need for personalized approach to treat ICU acquired delirium
December 14, 2018 - Soot particles from road traffic significantly contribute to air pollution
December 14, 2018 - Massage helps relieve pain, improve mobility in patients with knee osteoarthritis
December 14, 2018 - Researchers explore home healthcare nurses’ knowledge attitudes toward infection control
December 14, 2018 - Average outpatient visit in the U.S. costs nearly $500, shows new study
December 14, 2018 - Reference Infliximab, Biosimilar Equivalent for Crohn’s Disease
December 14, 2018 - New contact lens to treat eye injuries
December 14, 2018 - Acne could have a genetic basis find researchers promising new cure
December 14, 2018 - Higher physical activity associated with improved mood
December 14, 2018 - New UGA study points to optimal hypertension treatment for stroke patients
December 14, 2018 - Study highlights factors that can reduce food cravings
December 14, 2018 - Researchers discover Ebola-fighting protein in human cells
December 14, 2018 - Fentanyl surpasses heroin in cause of U.S. drug overdose deaths
December 14, 2018 - When Heart Attack Strikes, Women Often Hesitate to Call for Help
December 14, 2018 - A warning about costume contacts
December 14, 2018 - Study examines link between peripheral artery disease and heart attack
December 14, 2018 - Researchers develop biotechnological tool to produce antifungal proteins in plants
Sage launches new web-based tool that helps explore curated genomic analyses of Alzheimer’s

Sage launches new web-based tool that helps explore curated genomic analyses of Alzheimer’s

image_pdfDownload PDFimage_print

Sage Bionetworks announces the launch of the Agora platform (agora.ampadportal.org) an interactive, web-based tool that allows researchers to explore curated genomic analyses of Alzheimer’s Disease (AD), including a list of early candidate target nominations for AD. The analyses accessible through Agora represent the culmination of over five years of research from the dozens of scientists that are part of the NIH-led Accelerating Medicines Partnership – Alzheimer’s Disease (AMP-AD) Target Discovery and Preclinical Validation Project. AMP-AD is a precompetitive public private partnership led by NIH’s National Institute on Aging (NIA) and managed by the Foundation for the NIH (FNIH), bringing together the government, industry and non-profit sectors to transform the way disease-relevant therapeutic targets are discovered and validated.

The AMP-AD program has generated a wealth of genomic, RNA expression, proteomic, and metabolomic data from over 3000 human brain and plasma samples collected in several NIA-supported AD cohorts and brain banks. The raw and processed data have been made widely accessible to qualified researchers through the AMP-AD Knowledge Portal. The datasets available through the Knowledge Portal have been used by the AMP-AD consortia members to produce hundreds of novel scientific research papers. In addition to AMP-AD investigators, external researchers have benefitted from the data sharing policy mandating rapid and broad sharing of data and have made critical new observations, including a recently published study that highlighted a previously uncharacterized relationship of human herpes virus with AD.

Although use of primary data is typically limited to investigators with bioinformatic expertise, AMP-AD investigators have also generated analyses that should be useful to a broader set of researchers. The launch of the Agora portal represents the first time that the analyses have been shared outside of the AMP-AD consortia members, which should enable additional groundbreaking discoveries.

“Agora enables researchers to leverage AMP-AD analyses to advance their own scientific questions,” says Ben Logsdon, Director of Neurodegenerative Disease Research at Sage Bionetworks and the lead investigator on the Agora project. “These results were developed to answer questions posed by AMP-AD researchers, but they are broadly useful. Agora provides an easy tool to enable the exploration and reuse of these results by anyone.”

“The most exciting results featured in this early release of Agora is the AMP-AD nominated targets list – a set of genes and proteins derived from unbiased computational analyses of rich human multi-omics data,” said Suzana Petanceska, Ph.D., Program Director at the NIA, overseeing the AMP-AD Target Discovery Consortium. “These molecular signals could illuminate new disease biology or serve as novel therapeutic targets, she explained. “We are purposely releasing them at an early stage of the target evaluation process to allow us to integrate the input of external researchers and to crowdsource the follow-on evaluation,” added Petanceska.

“Because AMP-AD operates under open science principles, researchers rapidly disclose data and results and, in turn, they receive early peer review to help guide research decisions,” said Lara Mangravite, President of Sage Bionetworks and an AMP-AD Principal Investigator. “Agora extends this approach so that external investigators can get actively involved in evaluation of the AMP-AD targets as well as further their own research by evaluating the performance of their genes of interest against multiple computational meta-analyses.”

“AMP-AD is a clear response to the National Plan to Address Alzheimer’s Disease,” said Eliezer Masliah, M.D., director of the Division of Neuroscience at NIA. “It is enabling precision medicine and facilitating the principles of open science and rapid dissemination of new targets with more shots on goal for AD.”

Agora will be frequently updated to incorporate the latest analyses from AMP-AD and its affiliate AD consortia. The initial release includes differential expression and co-expression network meta-analyses across four human RNA-sequence data sets. Future releases will expand to include human proteomic and metabolomic analyses, comparative evaluations of disease signatures across species, and integration of druggability and tractability information to guide selection of targets for early drug discovery. Analyses developed within other consortia in the NIA’s AD Translational Research portfolio including MODEL-AD, M2OVE-AD, and AD Resilience will also be integrated into future iterations.

Source:

http://sagebionetworks.org/

Tagged with:

About author

Related Articles